ViewRay (VRAY) Prices 10.310M Share Common Offering at $4.85/Sh

Go back to ViewRay (VRAY) Prices 10.310M Share Common Offering at $4.85/Sh

ViewRay (VRAY) Announces Proposed Public Offering of Common Stock

January 4, 2021 5:06 PM UTC

ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced that it has commenced an underwritten public offering of shares of its common stock. In addition, ViewRay expects to grant the... More

ViewRay (VRAY) Shares Are Said to be Offered at $4.60 to $4.85 Each - Bloomberg

January 4, 2021 4:50 PM UTC

ViewRay (NASDAQ: VRAY) Shares Are Said to be Offered at $4.60 to $4.85 Each - Bloomberg

... More

ViewRay Inc. (VRAY) PT Raised to $6 at Cantor Fitzgerald

January 4, 2021 10:41 AM UTC

Cantor Fitzgerald analyst Brandon Folkes raised the price target on ViewRay Inc. (NASDAQ: VRAY) to $6.00 (from $4.00) while maintaining an Overweight rating.

The analyst commented, "Post preliminary 4Q20 results, we are reiterating our Overweight rating and raising our 12-month PT on VRAY shares to $6, from... More

ViewRay (VRAY) Announces Preliminary Q4 and FY Results

January 4, 2021 7:31 AM UTC

ViewRay, Inc. (NASDAQ: VRAY) today announced preliminary results for the fourth quarter and full fiscal year ended December 31, 2020. The preliminary results have not been audited and are subject to change.

Selected Fourth Quarter and Full Year 2020 Preliminary Results and Other Data (Unaudited):

Total revenue of approximately $18 million in the fourth quarter of 2020, primarily from three revenue units including one system upgrade, compared to total revenue of approximately $17 million, primarily from three revenue units including one system upgrade, in the fourth quarter of 2019.Received five new orders,... More